Showing results (231-240 of 691) with videos related to

Sort By:
Pageof 70
Multiple Sclerosis and Related Disorders|January 23, 2019
Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRIPhilipp Eisele, Simon Konstandin, Kristina Szabo, et al.
Oncoimmunology|August 17, 2017
K27M-mutant histone-3 as a novel target for glioma immunotherapyKatharina Ochs, Martina Ott, Theresa Bunse, et al.
Cancer|July 28, 2011
Bevacizumab and daily temozolomide for recurrent glioblastomaAnnick Desjardins, David A Reardon, April Coan, et al.
Cancer Chemotherapy and Pharmacology|June 3, 2019
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody-drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIIIMark Rosenthal, Richard Curry, David A Reardon, et al.
Neuro-Oncology|July 10, 2010
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label studyW K Alfred Yung, James J Vredenburgh, Timothy F Cloughesy, et al.
Cancer|April 4, 2003
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant gliomaDavid N Korones, Michal Benita-Weiss, Thomas E Coyle, et al.
Cancer Immunology Research|July 14, 2018
Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National CohortJ Bryan Iorgulescu, Maya Harary, Cheryl K Zogg, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 22, 2025
Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapyQi Wan, Clifford Lindsay, Chenxi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
World Neurosurgery|September 8, 2015
Adult Atypical Teratoid/Rhabdoid TumorsWinona W Wu, Wenya Linda Bi, Yun Jee Kang, et al.
Pageof 70